{"store":{"baseInfo":{"podcastTitle":"JNNP Podcast","slug":"jnnpbmj","podcastDescription":"The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP’s ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. \nEncompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.\n\nJoin Dr. Saima Chaudhry as she hosts in-depth interviews with authors, providing a deeper understanding of their work and shedding new light on their findings. Stay informed with expert discussions and cutting-edge information by subscribing or listening on your favourite podcast platform.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP_.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464412/JNNP__1200x628.jpg?s=ddcc6b04c88080de5342600b9bd70cfb&e=jpg","podcastUrl":"https://jnnpbmj.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/jnnpbmj/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-e9tb6-fb3a1c","removePodbeanBranding":"yes","brandingLogo":null,"timeZone":{"timeZoneId":30,"gmtAdjustment":"GMT+00:00","useDaylightTime":1,"value":0,"text":"(GMT+00:00) Greenwich Mean Time : Dublin, Edinburgh, Lisbon, London","daylightStartTime":"Last Sunday of March +1 Hours","daylightEndTime":"Last Sunday Of October +1 Hours","timezone":"Europe/London"},"podcastDownloads":null,"totalEpisodes":178,"showComments":false,"iOSAppDownloadLink":null,"customizeCssUrl":"https://s3.amazonaws.com/user-css.podbean.com/16464412/elegant/style.css","androidAppDownloadLink":null,"showPostShare":true,"showLike":false,"author":"BMJ Group","engagementStatsBaseUrl":"https://d1.podbean.com/webplayer_engagement?u=67d11946c5ef1b302404ea1b","shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-e9tb6-fb3a1c-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/gb/podcast/jnnp-podcast/id426391174","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fjnnpbmj.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16464412%26podcastIdTag%3De9tb6&dfl=https%3A%2F%2Fjnnpbmj.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/3VHlgiFD3LRw395wBB167T","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null},{"name":"Amazon Music","link":"https://music.amazon.com/podcasts/28d7a9ac-cf91-4e3b-9f79-7dbb4f59d48b","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/AmazonMusic.png","title":null},{"name":"TuneIn + Alexa","link":"https://tunein.com/podcasts/JNNP-podcast-p985596","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/tunein.png","title":null},{"name":"iHeartRadio","link":"https://www.iheart.com/podcast/256-jnnp-podcast-30964809/","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/iHeartRadio.png","title":null},{"name":"PlayerFM","link":"https://player.fm/series/jnnp-podcast-9877","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/PlayerFM.png","title":null},{"name":"Listen Notes","link":"https://www.listennotes.com/podcasts/jnnp-podcast-bmj-group-zycQJFEt87O/","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/ListenNotes.png","title":null},{"name":"Podchaser","link":"https://www.podchaser.com/podcasts/jnnp-podcast-151743","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/Podchaser.webp","title":null},{"name":"BoomPlay","link":"https://www.boomplaymusic.com/podcasts/82145","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/BoomPlay.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#679A35"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"hide"},{"id":"Favicon","val":"https://mcdn.podbean.com/mf/web/c3v67p/JNNP.jpg"},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/560MwnTqGugG","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-M9JKloTW5FLG","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[{"id":"ComponentText-ccb1c38c-9993-ad98-0ccc-b942d2290eae","val":{"ComponentFontColor":"#000000","ComponentBackgroundColor":"#f2f2f2","ComponentContent":"

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

"}}]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.generic","app_store_id":1484287462,"app_name":"Podbean Biz Podcast App","scheme":"enterprise-podbean-com"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":false,"enableWebSiteLike":false,"organizationName":"BMJ Podcasts","organizationPageLink":"https://www.podbean.com/podcast-network/BMJPodcasts"},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://jnnpbmj.podbean.com","apiCommonParams":{"t":"67d11946","clientSignature":"7745831f4d5ca8cf9c28e05af7eccbbe","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":null,"commentsTotalPage":null,"commentsPage":null,"commentEpisodeId":null,"episode":{"id":"pb21027159","idTag":"uyeif","title":"Immunomodulatory therapy in advanced multiple sclerosis","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP__300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464412/JNNP__1200x628.jpg?s=ddcc6b04c88080de5342600b9bd70cfb&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP_.jpg","previewContent":null,"content":"Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? \nTomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton.\n

Read the full article here: http://jnnp.bmj.com/content/88/3/196.

","publishTimestamp":1486997040,"duration":845,"mediaUrl":"https://mcdn.podbean.com/mf/web/ko276s/stream_307513111-bmjgroup-immunomodulatory-therapy-in-advanced-multiple-sclerosis.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-uyeif-140d957","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-uyeif-140d957","transcriptUrl":null,"permalink":"/e/immunomodulatory-therapy-in-advanced-multiple-sclerosis/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB140D957UYEIF","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":44,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-uyeif-140d957","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb21027159","idTag":"uyeif","title":"Immunomodulatory therapy in advanced multiple sclerosis","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP__300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464412/JNNP__1200x628.jpg?s=ddcc6b04c88080de5342600b9bd70cfb&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP_.jpg","previewContent":null,"content":"Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? \nTomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton.\n

Read the full article here: http://jnnp.bmj.com/content/88/3/196.